Hosted on MSN
Merck nears $10 billion deal for biotech Verona
US drugmaker Merck is nearing a deal worth about $10 billion to buy Verona Pharma, a company focused on therapies for lung diseases, the Financial Times reported on Wednesday.Merck will pay $107 per ...
Hosted on MSN
Merck nears $10 bn deal for respiratory drugmaker Verona: Reports
Merck is nearing a roughly $10 billion deal to buy lung disease-focused biotech Verona Pharma, the Financial Times reported on Wednesday. Merck would pay $107 per American depository share for Verona, ...